Tonner et al., J Endocrinol 2000
:
Since alpha ( s2 ) -casein also binds plasminogen and tissue-type plasminogen activator ( t-PA ), resulting in the conversion of plasminogen to plasmin, and since IGFBP-5 binds to plasminogen activator inhibitor-1 ( PAI-1 ), we investigated whether apoptosis and extracellular matrix ( ECM ) degradation might be coordinately controlled by GH and PRL possibly acting through IGFBP-5
Prysor-Jones et al., Acta Endocrinol (Copenh) 1985
(Pituitary Neoplasms) :
The presence of ECM caused an increase in Prl but a decrease in GH ... On one cell line the Prl response to thyrotrophin releasing hormone (TRH) was increased by ECM